We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 257

Life Sciences International Review Q2 2018
  • Morgan Lewis & Bockius LLP
  • USA, United Kingdom, European Union, France
  • June 6 2018

The most-significant recent development is the entry into force on 25 May of the EU General Data Protection Regulation. This new legislation will have

International Life Sciences Review: Issue 8
  • Morgan Lewis & Bockius LLP
  • USA, Netherlands, China, European Union, France, Global
  • February 6 2018

The European Commission has published the Draft Regulation amending Regulation (EC) No 8472000 as regards the definition of the concept 'similar

Recent developments in biosimilars: Canada, EU, France and the U.S.
  • Norton Rose Fulbright Canada LLP
  • USA, Canada, European Union, France
  • January 29 2014

There have been a number of developments in biosimilars of late, including regulatory approvals in Canada issued on January 15, 2014 for two

Jonathan E. Canis
  • Arent Fox LLP

Paul Ranson
  • Morgan Lewis & Bockius LLP

Simon Castley
  • Shook Hardy & Bacon LLP

Stewart A. Baker
  • Steptoe & Johnson LLP

Mark D. Anstoetter
  • Shook Hardy & Bacon LLP

Toby Patten
  • Baker McKenzie